DAY ONE BIOPHARMACEUTICALS I's ticker is DAWN and the CUSIP is 23954D109. A total of 67 filers reported holding DAY ONE BIOPHARMACEUTICALS I in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.8%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $57,527,084 | +35.2% | 4,688,434 | +31.5% | 0.00% | +100.0% |
| Q2 2023 | $42,562,912 | +41.0% | 3,564,733 | +57.8% | 0.00% | 0.0% |
| Q1 2023 | $30,196,078 | -42.4% | 2,258,495 | -7.3% | 0.00% | -50.0% |
| Q4 2022 | $52,406,969 | +3.0% | 2,435,268 | -4.2% | 0.00% | 0.0% |
| Q3 2022 | $50,901,000 | +44.9% | 2,541,235 | +29.5% | 0.00% | +100.0% |
| Q2 2022 | $35,132,000 | +204.5% | 1,962,724 | +68.8% | 0.00% | – |
| Q1 2022 | $11,537,000 | -9.0% | 1,162,916 | +54.6% | 0.00% | – |
| Q4 2021 | $12,672,000 | +2.4% | 752,119 | +44.3% | 0.00% | – |
| Q3 2021 | $12,370,000 | +12394.9% | 521,273 | +11823.0% | 0.00% | – |
| Q2 2021 | $99,000 | – | 4,372 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Canaan Partners XI LLC | 9,663,645 | $95,863,000 | 39.92% |
| Atlas Venture Life Science Advisors, LLC | 8,201,638 | $81,360,000 | 10.29% |
| RA Capital Management | 6,060,090 | $60,116,000 | 1.31% |
| Boxer Capital, LLC | 1,189,943 | $11,804,000 | 0.61% |
| Samsara BioCapital, LLC | 202,500 | $2,009,000 | 0.51% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 2,086,449 | $20,698,000 | 0.46% |
| BVF INC/IL | 809,282 | $8,028,000 | 0.32% |
| Summit Rock Advisors, LP | 33,125 | $329,000 | 0.20% |
| Perceptive Advisors | 556,047 | $5,516,000 | 0.11% |
| Nan Fung Group Holdings Ltd | 11,445 | $114,000 | 0.05% |